Zhenxun Wang

448 total citations
23 papers, 273 citations indexed

About

Zhenxun Wang is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zhenxun Wang has authored 23 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Orthopedics and Sports Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Zhenxun Wang's work include Bone health and osteoporosis research (8 papers), Bone health and treatments (6 papers) and Bone and Joint Diseases (5 papers). Zhenxun Wang is often cited by papers focused on Bone health and osteoporosis research (8 papers), Bone health and treatments (6 papers) and Bone and Joint Diseases (5 papers). Zhenxun Wang collaborates with scholars based in United States, United Kingdom and Belgium. Zhenxun Wang's co-authors include Mary Oates, Haitao Chu, Arkadi Chines, Lifeng Lin, Bente Langdahl, James S. Hodges, Cesar Libanati, Evelien Gielen, Zhigang Yu and Ian R. Reid and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Virology and Journal of Bone and Mineral Research.

In The Last Decade

Zhenxun Wang

22 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenxun Wang United States	9	117	86	82	37	37	23	273
Sabashini K. Ramchand Australia	11	155 1.3×	174 2.0×	101 1.2×	49 1.3×	14 0.4×	28	347
Xiaohai Wan United States	12	311 2.7×	203 2.4×	156 1.9×	124 3.4×	6 0.2×	24	466
Peter Jackuliak Slovakia	10	200 1.7×	93 1.1×	131 1.6×	43 1.2×	7 0.2×	53	448
Satoshi Ikeda Japan	9	129 1.1×	75 0.9×	47 0.6×	56 1.5×	6 0.2×	20	221
Audrey Kriegman United States	7	358 3.1×	292 3.4×	130 1.6×	47 1.3×	4 0.1×	9	410
Eun Heui Kim South Korea	13	20 0.2×	71 0.8×	41 0.5×	62 1.7×	18 0.5×	37	331
B. Mitlak Belgium	4	293 2.5×	191 2.2×	100 1.2×	88 2.4×	4 0.1×	6	335
Kristen Whitaker United States	7	42 0.4×	74 0.9×	34 0.4×	23 0.6×	3 0.1×	11	229
Michail Varras Greece	11	22 0.2×	35 0.4×	94 1.1×	63 1.7×	11 0.3×	26	311
Stefania Salvadori Italy	9	166 1.4×	117 1.4×	78 1.0×	65 1.8×	2 0.1×	10	326

Countries citing papers authored by Zhenxun Wang

Since Specialization

Citations

This map shows the geographic impact of Zhenxun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenxun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenxun Wang more than expected).

Fields of papers citing papers by Zhenxun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenxun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenxun Wang. The network helps show where Zhenxun Wang may publish in the future.

Co-authorship network of co-authors of Zhenxun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenxun Wang. A scholar is included among the top collaborators of Zhenxun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenxun Wang. Zhenxun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrari, Serge, Robert G. Feldman, Bente Langdahl, et al.. (2025). Romosozumab Improves Tissue Thickness–Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(10). 2861–2868. 1 indexed citations

Cosman, Felicia, Zhenxun Wang, Xiaodong Li, & Steven R. Cummings. (2025). Probability of achieving bone mineral density treatment goals with denosumab treatment in postmenopausal women with osteoporosis. Journal of Bone and Mineral Research. 40(6). 766–772. 1 indexed citations

Cosman, Felicia, et al.. (2024). Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension. Journal of Bone and Mineral Research. 39(9). 1268–1277. 8 indexed citations

Lane, Joseph M., Bente Langdahl, Mike Stone, et al.. (2024). Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis International. 35(7). 1195–1204. 4 indexed citations

Camenga, Deepa R., Zhenxun Wang, Haitao Chu, et al.. (2023). Sexual Health Behaviors by Age 17 and Lower Urinary Tract Symptoms at Age 19: PLUS Research Consortium Analysis of ALSPAC Data. Journal of Adolescent Health. 72(5). 737–745. 1 indexed citations

Lane, Nancy E., et al.. (2023). Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial. ACR Open Rheumatology. 6(1). 43–51. 6 indexed citations

Langdahl, Bente, Lorenz C. Hofbauer, Serge Ferrari, et al.. (2022). Romosozumab efficacy and safety in European patients enrolled in the FRAME trial. Osteoporosis International. 33(12). 2527–2536. 8 indexed citations

Paller, Amy S., Elaine C. Siegfried, S.E. Marrón, et al.. (2022). 147 Development and validation of a caregiver-reported numeric rating scale for measuring pruritus in children aged 6 months to <6 years with atopic dermatitis. Journal of Investigative Dermatology. 142(8). S25–S25. 1 indexed citations

Cork, Michael J., et al.. (2022). Efficacy and safety of dupilumab in children aged 6–11 years with inadequately controlled severe atopic dermatitis: Results from an open-label extension trial up to 1 year. Revue française d'allergologie. 62(3). 321–321.

10.

Chapurlat, Roland, Joop P. van den Bergh, Stuart H. Ralston, et al.. (2022). Proportion of Patients Who Reach the BMD Surrogate Threshold Effect on Romosozumab: a Post Hoc Analysis of the Randomised FRAME and ARCH Phase 3 Trials. Bone Reports. 16. 101194–101194. 1 indexed citations

11.

Brown, Jacques P., Klaus Engelke, Tony M. Keaveny, et al.. (2021). Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. Journal of Bone and Mineral Research. 36(11). 2139–2152. 44 indexed citations

12.

Geusens, Piet, Robert Feldman, Mary Oates, et al.. (2021). Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosis. Bone. 154. 116209–116209. 12 indexed citations

13.

Cosman, Felicia, Cesar Libanati, Zhigang Yu, et al.. (2021). Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals. JBMR Plus. 5(11). e10546–e10546. 9 indexed citations

14.

Wang, Simin, Zhenxun Wang, Ruimin Li, et al.. (2021). Association between quantitative and qualitative image features of contrast-enhanced mammography and molecular subtypes of breast cancer. Quantitative Imaging in Medicine and Surgery. 12(2). 1270–1280. 17 indexed citations

15.

Shoham, David A., Zhenxun Wang, Sarah Lindberg, et al.. (2020). School Toileting Environment, Bullying, and Lower Urinary Tract Symptoms in a Population of Adolescent and Young Adult Girls: Preventing Lower Urinary Tract Symptoms Consortium Analysis of Avon Longitudinal Study of Parents and Children. Urology. 151. 86–93. 10 indexed citations

16.

Wang, Zhenxun, Lifeng Lin, James S. Hodges, Richard F. MacLehose, & Haitao Chu. (2020). A variance shrinkage method improves arm-based Bayesian network meta-analysis. Statistical Methods in Medical Research. 30(1). 151–165. 6 indexed citations

17.

Wang, Zhenxun, Lifeng Lin, James S. Hodges, & Haitao Chu. (2020). The impact of covariance priors on arm‐based Bayesian network meta‐analyses with binary outcomes. Statistics in Medicine. 39(22). 2883–2900. 14 indexed citations

18.

Miller, Paul D., Jonathan D. Adachi, Ben‐Hur Albergaria, et al.. (2020). Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease. Journal of Bone and Mineral Research. 37(8). 1437–1445. 58 indexed citations

19.

Wang, Simin, Zhenxun Wang, Chi‐Hua Chen, et al.. (2019). Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes. Acta Diabetologica. 56(9). 1061–1071. 5 indexed citations

20.

Yu, Xianming, et al.. (2012). Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus. Journal of Virology. 86(15). 8086–8096. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact